[Efficacy and Side Effects of Lutetium-177 PSMA-617 in Patients with Castration Resistant Metastatic Prostate Cancer: A Systematic Review and Meta- analysis]
{{output}}
Background: Progression of metastatic prostate cancer after castration resistance is one of the main challenges in prostate cancer therapy. 177Lu-PSMA-617 has been recently investigated in castration resistant metastatic prostate... ...
